The U.S. Food and Drug Administration (FDA) has extended the review period for mitapivat as a potential treatment for…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
Vitamin D deficiency in children and adolescents with sickle cell disease (SCD) was consistently associated with worse clinical and…
A research team at the Icahn School of Medicine at Mount Sinai has received a $4.1 million grant to investigate…
Higher vitamin A levels in the blood were significantly associated with better lung function in children and adolescents with sickle…
Casgevy (exagamglogene autotemcel) will be reimbursed by Germany’s public health system, enabling people with severe sickle cell disease…
Women with sickle cell anemia (SCA), the most common and severe form of sickle cell disease (SCD), have significantly lower…
Agios Pharmaceuticals is planning to file an application with the U.S. Food and Drug Administration (FDA) in the coming…
The Japan Agency for Medical Research and Development (AMED) — a national funding agency created to support medical R&D in…
Adults with sickle cell disease (SCD) face a substantial risk of stroke, most often in their 30s and 40s,…
A blood test measuring levels of the protein cystatin C may provide a more reliable way to monitor for…